152 related articles for article (PubMed ID: 20381955)
1. Novel in vivo model of inducible multi-drug resistance in acute lymphoblastic leukemia with chromosomal translocation t(4;11).
Zunino SJ; Storms DH; Ducore JM
Cancer Lett; 2010 Oct; 296(1):49-54. PubMed ID: 20381955
[TBL] [Abstract][Full Text] [Related]
2. Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2012 Dec; 41(6):2207-12. PubMed ID: 23041950
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2012 Apr; 40(4):1277-84. PubMed ID: 22200740
[TBL] [Abstract][Full Text] [Related]
4. Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.
Zunino SJ; Storms DH; Newman JW; Pedersen TL; Keen CL; Ducore JM
Int J Oncol; 2013 Feb; 42(2):741-8. PubMed ID: 23232667
[TBL] [Abstract][Full Text] [Related]
5. A human acute lymphoblastic leukemia line with the T(4;11) translocation as a model of minimal residual disease in SCID mice.
Gobbi A; Di Berardino C; Scanziani E; Garofalo A; Rivolta A; Fontana G; Rambaldi A; Giavazzi R; Biondi A
Leuk Res; 1997; 21(11-12):1107-14. PubMed ID: 9444945
[TBL] [Abstract][Full Text] [Related]
6. BCL-2 expression by leukaemic blasts in a SCID mouse model of biphenotypic leukaemia associated with the t(4;11)(q21;q23) translocation.
Pocock CF; Malone M; Booth M; Evans M; Morgan G; Greil J; Cotter FE
Br J Haematol; 1995 Aug; 90(4):855-67. PubMed ID: 7669664
[TBL] [Abstract][Full Text] [Related]
7. A novel case of acute lymphoblastic leukemia with t(1;4;6;11)(q31;q27;q22;q23).
Patel DM; Patel GH; Brahmbhatt MM; Trivedi PJ; Shukla SN; Patel PS
Int J Lab Hematol; 2012 Dec; 34(6):e9-e11. PubMed ID: 22846102
[No Abstract] [Full Text] [Related]
8. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?
Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E
Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086
[No Abstract] [Full Text] [Related]
9. A Novel t(4;11)(q21;q23) MLL-AF4 fusion transcript in infant leukemia.
Abdelhaleem M; Yi Q; Beimnet K; Grant R
Am J Hematol; 2007 Mar; 82(3):247. PubMed ID: 16924642
[No Abstract] [Full Text] [Related]
10. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
11. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of engraftment and progression of acute lymphoblastic leukemia in individual NOD/SCID mice.
Nijmeijer BA; Mollevanger P; van Zelderen-Bhola SL; Kluin-Nelemans HC; Willemze R; Falkenburg JH
Exp Hematol; 2001 Mar; 29(3):322-9. PubMed ID: 11274760
[TBL] [Abstract][Full Text] [Related]
13. MLL/AF-4 leukemic cells recruit new blood vessels but do not incorporate into capillaries in culture or in a NOD/SCID xenograft model.
Hu Z; Li XM; Jorgensen ML; Slayton WB
Leukemia; 2009 May; 23(5):990-3. PubMed ID: 19158831
[No Abstract] [Full Text] [Related]
14. Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Chelstrom LM; Gunther R; Ryan M; Simon J; Carroll AJ; Tuel-Ahlgren L; Crist WM
Blood; 1994 Aug; 84(3):859-65. PubMed ID: 8043867
[TBL] [Abstract][Full Text] [Related]
15. Relapse as acute monocytic leukaemia of acute lymphoblastic leukaemia with t(4;11).
Daniel MT; Jonveaux P; Berger R
Nouv Rev Fr Hematol (1978); 1992; 34(4):347-8. PubMed ID: 1448357
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB activation mediates resistance to IFN beta in MLL-rearranged acute lymphoblastic leukemia.
Tracey L; Streck CJ; Du Z; Williams RF; Pfeffer LM; Nathwani AC; Davidoff AM
Leukemia; 2010 Apr; 24(4):806-12. PubMed ID: 20130599
[TBL] [Abstract][Full Text] [Related]
17. Acute lymphoblastic leukemia with t(4;11) translocation after osteogenic sarcoma.
Kapelushnik J; Dubé I; Wilson P; Greenberg M
Cancer; 1991 Jun; 67(11):2887-9. PubMed ID: 2025854
[TBL] [Abstract][Full Text] [Related]
18. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
[TBL] [Abstract][Full Text] [Related]
19. Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivo.
Kang MH; Kang YH; Szymanska B; Wilczynska-Kalak U; Sheard MA; Harned TM; Lock RB; Reynolds CP
Blood; 2007 Sep; 110(6):2057-66. PubMed ID: 17536015
[TBL] [Abstract][Full Text] [Related]
20. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]